Cargando…

State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid

OBJECTIVE: Early administration of tranexamic acid (TXA) has been shown to save lives in trauma patients, and some U.S. emergency medical systems (EMS) have begun providing this therapy prehospital. Treatment protocols vary from state to state: Some offer TXA broadly to major trauma patients, others...

Descripción completa

Detalles Bibliográficos
Autores principales: Bivens, Matthew J., Fritz, Christie L., Burke, Ryan C., Schoenfeld, David W., Pope, Jennifer V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719138/
https://www.ncbi.nlm.nih.gov/pubmed/36463125
http://dx.doi.org/10.1186/s12873-022-00741-2
_version_ 1784843251772030976
author Bivens, Matthew J.
Fritz, Christie L.
Burke, Ryan C.
Schoenfeld, David W.
Pope, Jennifer V.
author_facet Bivens, Matthew J.
Fritz, Christie L.
Burke, Ryan C.
Schoenfeld, David W.
Pope, Jennifer V.
author_sort Bivens, Matthew J.
collection PubMed
description OBJECTIVE: Early administration of tranexamic acid (TXA) has been shown to save lives in trauma patients, and some U.S. emergency medical systems (EMS) have begun providing this therapy prehospital. Treatment protocols vary from state to state: Some offer TXA broadly to major trauma patients, others reserve it for patients meeting vital sign criteria, and still others defer TXA entirely pending a hospital evaluation. The purpose of this study is to compare the avoidable mortality achievable under each of these strategies, and to report on the various approaches used by EMS. METHODS: We used the National Center for Health Statistics Underlying Cause of Death data to identify a TXA-naïve population of trauma patients who died from 2007 to 2012 due to hemorrhage. We estimated the proportion of deaths where the patient was hypotensive or tachycardic using the National Trauma Data Bank. We used avoidable mortality risk ratios from the landmark CRASH 2 study to calculate lives saved had TXA been given within one hour of injury based on a clinician’s gestalt the patient was at risk for significant hemorrhage; had it been reserved only for hypotensive or tachycardic patients; or had it been given between hours one to three of injury, considered here as a surrogate for deferring the question to the receiving hospital. RESULTS: Had TXA been given within 1 hour of injury, an average of 3409 deaths per year could have been averted nationally. Had TXA been given between one and three hours after injury, 2236 deaths per year could have been averted. Had TXA only been given to either tachycardic or hypotensive trauma patients, 1371 deaths per year could have been averted. Had TXA only been given to hypotensive trauma patients, 616 deaths per year could have been averted. Similar trends are seen at the individual state level. A review of EMS practices found 15 statewide protocols that allow EMS providers to administer TXA for trauma. CONCLUSION: Providing early TXA to persons at risk of significant hemorrhage has the potential to prevent many deaths from trauma, yet most states do not offer it in statewide prehospital treatment protocols. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12873-022-00741-2.
format Online
Article
Text
id pubmed-9719138
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97191382022-12-04 State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid Bivens, Matthew J. Fritz, Christie L. Burke, Ryan C. Schoenfeld, David W. Pope, Jennifer V. BMC Emerg Med Research OBJECTIVE: Early administration of tranexamic acid (TXA) has been shown to save lives in trauma patients, and some U.S. emergency medical systems (EMS) have begun providing this therapy prehospital. Treatment protocols vary from state to state: Some offer TXA broadly to major trauma patients, others reserve it for patients meeting vital sign criteria, and still others defer TXA entirely pending a hospital evaluation. The purpose of this study is to compare the avoidable mortality achievable under each of these strategies, and to report on the various approaches used by EMS. METHODS: We used the National Center for Health Statistics Underlying Cause of Death data to identify a TXA-naïve population of trauma patients who died from 2007 to 2012 due to hemorrhage. We estimated the proportion of deaths where the patient was hypotensive or tachycardic using the National Trauma Data Bank. We used avoidable mortality risk ratios from the landmark CRASH 2 study to calculate lives saved had TXA been given within one hour of injury based on a clinician’s gestalt the patient was at risk for significant hemorrhage; had it been reserved only for hypotensive or tachycardic patients; or had it been given between hours one to three of injury, considered here as a surrogate for deferring the question to the receiving hospital. RESULTS: Had TXA been given within 1 hour of injury, an average of 3409 deaths per year could have been averted nationally. Had TXA been given between one and three hours after injury, 2236 deaths per year could have been averted. Had TXA only been given to either tachycardic or hypotensive trauma patients, 1371 deaths per year could have been averted. Had TXA only been given to hypotensive trauma patients, 616 deaths per year could have been averted. Similar trends are seen at the individual state level. A review of EMS practices found 15 statewide protocols that allow EMS providers to administer TXA for trauma. CONCLUSION: Providing early TXA to persons at risk of significant hemorrhage has the potential to prevent many deaths from trauma, yet most states do not offer it in statewide prehospital treatment protocols. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12873-022-00741-2. BioMed Central 2022-12-03 /pmc/articles/PMC9719138/ /pubmed/36463125 http://dx.doi.org/10.1186/s12873-022-00741-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Bivens, Matthew J.
Fritz, Christie L.
Burke, Ryan C.
Schoenfeld, David W.
Pope, Jennifer V.
State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid
title State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid
title_full State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid
title_fullStr State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid
title_full_unstemmed State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid
title_short State-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid
title_sort state-by-state estimates of avoidable trauma mortality with early and liberal versus delayed or restricted administration of tranexamic acid
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719138/
https://www.ncbi.nlm.nih.gov/pubmed/36463125
http://dx.doi.org/10.1186/s12873-022-00741-2
work_keys_str_mv AT bivensmatthewj statebystateestimatesofavoidabletraumamortalitywithearlyandliberalversusdelayedorrestrictedadministrationoftranexamicacid
AT fritzchristiel statebystateestimatesofavoidabletraumamortalitywithearlyandliberalversusdelayedorrestrictedadministrationoftranexamicacid
AT burkeryanc statebystateestimatesofavoidabletraumamortalitywithearlyandliberalversusdelayedorrestrictedadministrationoftranexamicacid
AT schoenfelddavidw statebystateestimatesofavoidabletraumamortalitywithearlyandliberalversusdelayedorrestrictedadministrationoftranexamicacid
AT popejenniferv statebystateestimatesofavoidabletraumamortalitywithearlyandliberalversusdelayedorrestrictedadministrationoftranexamicacid